New hope for Africa as WHO green-lights first malaria vaccine


New hope for Africa as WHO green-lights first malaria vaccine

The shot is the first to prove safe and effective in a large trial and could save hundreds of thousands of lives

James Paton and Joel Leon

The first vaccine for malaria, the mosquito-borne disease that kills 400,000 people each year, is set to be deployed more widely after more than three decades of work and about $1bn (about R15bn) in investment.

The vaccine, developed by GlaxoSmithKline and its partners, won a recommendation from the World Health Organisation (WHO) on Wednesday for use in children in sub-Saharan Africa and other regions with moderate to high transmission. It marks a turning point in a battle against the parasite that causes malaria. 

The shot prevented only about four in 10 malaria cases among children who received four doses in a large study, but the injection, along with other measures, could still save hundreds of thousands of lives. Now the focus will shift to getting it to more people after a pilot programme in Africa that began in 2019. ..

This article is free to read if you register or sign in.

Sunday Times Daily

If you have already registered or subscribed, please sign in to continue.

Questions or problems?
Email or call 0860 52 52 00.

Next Article

Previous Article